ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank92
3Y CAGR+155.9%
5Y CAGR+92.4%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+155.9%/yr
vs -41.5%/yr prior
5Y CAGR
+92.4%/yr
Recent acceleration
Acceleration
+197.4pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
26.4x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.01% |
| Q3 2025 | 8.27% |
| Q2 2025 | 2.90% |
| Q1 2025 | 2.63% |
| Q4 2024 | -0.74% |
| Q3 2024 | -10.75% |
| Q2 2024 | -0.36% |
| Q1 2024 | 3.68% |
| Q4 2023 | -0.00% |
| Q3 2023 | -1.96% |
| Q2 2023 | 18.60% |
| Q1 2023 | -0.13% |
| Q4 2022 | 0.42% |
| Q3 2022 | -0.27% |
| Q2 2022 | -3.45% |
| Q1 2022 | -15.29% |
| Q4 2021 | 58.99% |
| Q3 2021 | 0.04% |
| Q2 2021 | -6.20% |
| Q1 2021 | 4.02% |
| Q4 2020 | 0.27% |
| Q3 2020 | 1.76% |
| Q2 2020 | -5.55% |
| Q1 2020 | -5.44% |
| Q4 2019 | -0.22% |
| Q3 2019 | 2.39% |
| Q2 2019 | 3.07% |
| Q1 2019 | 1.09% |
| Q4 2018 | 2.28% |
| Q3 2018 | 3.73% |
| Q2 2018 | 2.25% |
| Q1 2018 | 2.54% |
| Q4 2017 | -4.46% |
| Q3 2017 | 3.48% |
| Q2 2017 | 2.35% |
| Q1 2017 | 1.42% |
| Q4 2016 | 0.03% |
| Q3 2016 | 2.52% |
| Q2 2016 | 2.18% |
| Q1 2016 | 0.31% |